iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/32235174
A Narrative Review of Current Challenges in the Diagnosis and Management of Bacterial Vaginosis - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;47(7):441-446.
doi: 10.1097/OLQ.0000000000001178.

A Narrative Review of Current Challenges in the Diagnosis and Management of Bacterial Vaginosis

Christina A Muzny  1 , Przemyslaw Kardas  2
Affiliations
Review

A Narrative Review of Current Challenges in the Diagnosis and Management of Bacterial Vaginosis

Christina A Muzny et al. Sex Transm Dis. 2020 Jul.

Abstract

Despite the availability of a number of oral and intravaginal antibiotic medications for the treatment of bacterial vaginosis (BV), management of this condition remains challenging. Recurrent BV occurs in >50% of patients receiving guideline-recommended treatments. This may be due to persistence or resurgence of the BV biofilm after treatment cessation, failure to reestablish an optimal vaginal microbiome after treatment, reinfection from an untreated sexual partner, or a combination of these factors. Nonadherence to multidose BV therapies may potentially contribute to recurrent BV, although there are no published data that directly assess the role of nonadherence to poor treatment outcomes and recurrent BV. There is a need for studies of BV treatment adherence in real-world settings as well as studies to explore the relationship between treatment adherence and recurrence. This review explores challenges associated with diagnosing and treating BV, current multidose antibiotic treatment options, newer single-dose treatment options, and ways to potentially maximize treatment success for this common vaginal infection.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest and Sources of Funding: C.A.M. has received research grant support from the National Institute of Allergy and Infectious Diseases, is a consultant for Lupin Pharmaceuticals and BioFire Diagnostics, and has received honoraria from Lupin Pharmaceuticals, Cepheid, Becton Dickinson, and Roche Diagnostics. P.K. reports no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001–2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109:114–120. - PubMed
    1. Peebles K, Velloza J, Balkus JE, et al. High global burden and costs of bacterial vaginosis: A systematic review and meta-analysis. Sex Transm Dis 2019; 46:304–311. - PubMed
    1. Fethers KA, Fairley CK, Hocking JS, et al. Sexual risk factors and bacterial vaginosis: A systematic review and meta-analysis. Clin Infect Dis 2008; 47:1426–1435. - PubMed
    1. Kenyon CR, Buyze J, Klebanoff M, et al. Association between bacterial vaginosis and partner concurrency: A longitudinal study. Sex Transm Infect 2018; 94:75–77. - PMC - PubMed
    1. Bradshaw CS, Walker SM, Vodstrcil LA, et al. The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: The WOW Health Study. J Infect Dis 2014; 209:1562–1572. - PubMed

Publication types

Substances